Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.440
+0.010 (0.29%)
At close: Aug 18, 2026, 4:00 PM EDT
3.316
-0.124 (-3.61%)
After-hours: Aug 18, 2026, 7:56 PM EDT

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
14480273875281
Market Cap Growth
188.34%202.37%-30.71%-48.99%-73.29%328.57%
Enterprise Value
11883313957243
Last Close Price
3.442.712.204.6011.1047.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
42.4865.49----
PB Ratio
--5.03-1.14-3.2610.1313.51
P/TBV Ratio
----10.1313.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
34.8668.00----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.91-0.04-0.27-0.781.420.03
Net Debt / Equity Ratio
152.070.45-0.21-0.39-1.29-1.30
Net Debt / EBITDA Ratio
1.310.45-0.24-0.170.220.29
Net Debt / FCF Ratio
1.250.51-0.45-0.210.240.72
Asset Turnover
0.170.15----
Quick Ratio
0.790.280.070.241.292.32
Current Ratio
0.860.310.150.361.662.74
Return on Equity (ROE)
-----281.79%-
Return on Assets (ROA)
-63.99%-121.85%-224.60%-104.08%-94.66%-330.91%
Return on Capital Employed (ROCE)
-6980.40%103.60%108.20%235.10%-433.30%-453.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.29%-35.68%-94.69%-78.73%-52.95%-33.11%
FCF Yield
-14.34%-17.59%-40.09%-56.56%-52.96%-13.41%
Buyback Yield / Dilution
-110.42%-101.06%-40.50%-15.20%-40.17%-36.90%
SEC Filings: 10-K · 10-Q